Rheumatoid Arthritis

CORONAVIRUS (COVID-19) 1 Credit CME Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US JAMA Internal Medicine

CLINICAL PHARMACY AND PHARMACOLOGY 1 Credit CME Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial JAMA

CLINICAL CHALLENGE 1 Credit CME Soft Palate Ulcer—Benign or Malignant? JAMA Otolaryngology–Head & Neck Surgery

RHEUMATOID ARTHRITIS 1 Credit CME Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial JAMA

RHEUMATOID ARTHRITIS 1 Credit CME Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial JAMA

ADVERSE DRUG EVENTS 1 Credit CME Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events JAMA Neurology

DERMATOLOGY 1 Credit CME Melanoma Risk in Patients Treated With Biologic Therapy for Common Inflammatory Diseases: A Systematic Review and Meta-analysis JAMA Dermatology

RHEUMATOID ARTHRITIS 1 Credit CME Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial JAMA

RADIOLOGY 1 Credit CME Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial JAMA

RHEUMATOLOGY 5m 49s Association Between the Initiation of Anti-Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster JAMA